Study Name,SiteGroupName(CountryName),SiteNumber,SubjectName,Overall Subject Status,Form 1 Subject Status,FolderName,Form Type (Summary or Visit),Visit date,No. #Days Page Missing
Study 6,AUS,Site 14,Subject 25,Screen Failure,Subject discontinued from study at this visit,Screening,Form 1,5 JUN 2025,162
Study 6,AUS,Site 14,Subject 26,On Trial,,Cycle 2 Week 8,Form 1,Missing visit date,
Study 6,AUS,Site 14,Subject 27,Follow-Up,,Antineoplastic CM,Form 2,,
Study 6,AUS,Site 14,Subject 27,Follow-Up,,Antineoplastic RT,Form 2,,
Study 6,AUS,Site 14,Subject 27,Follow-Up,,Antineoplastic RT,Form 2,,
Study 6,AUS,Site 14,Subject 27,Follow-Up,,Antineoplastic Surgery,Form 2,,
Study 6,AUS,Site 14,Subject 27,Follow-Up,,Antineoplastic Surgery,Form 2,,
Study 6,AUS,Site 14,Subject 27,Follow-Up,,Long term follow-up 1,Form 1,Missing visit date,
Study 6,AUS,Site 14,Subject 28,Screen Failure,Subject discontinued from study at this visit,Screening,Form 1,24 JUL 2025,113
Study 6,AUS,Site 14,Subject 29,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,11 NOV 2025,3
Study 6,AUS,Site 14,Subject 29,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,11 NOV 2025,3
Study 6,AUS,Site 14,Subject 29,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,11 NOV 2025,3
Study 6,AUS,Site 14,Subject 29,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,11 NOV 2025,3
Study 6,AUS,Site 14,Subject 29,On Trial,,Cycle 2 Week 3,Form 1,Missing visit date,
Study 6,AUS,Site 14,Subject 30,On Trial,,Cycle 1 Week 8,Form 1,Missing visit date,
Study 6,AUS,Site 14,Subject 31,On Trial,,Cycle 1 Week 8,Form 1,Missing visit date,
Study 6,AUS,Site 14,Subject 32,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,13 OCT 2025,32
Study 6,AUS,Site 14,Subject 32,On Trial,,Cycle 1 Week 7,Form 1,Missing visit date,
Study 6,AUS,Site 14,Subject 33,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,14 OCT 2025,31
Study 6,AUS,Site 14,Subject 33,On Trial,,Cycle 1 Week 7,Form 1,Missing visit date,
Study 6,AUS,Site 14,Subject 34,Screen Failure,Subject discontinued from study at this visit,Screening,Form 1,23 OCT 2025,22
Study 6,AUS,Site 14,Subject 35,Screening,,Disposition,Form 2,,
Study 6,AUS,Site 14,Subject 35,Screening,Subject continuing,Screening,Form 1,28 OCT 2025,17
Study 6,AUS,Site 14,Subject 35,Screening,Subject continuing,Screening,Form 1,28 OCT 2025,17
Study 6,AUS,Site 14,Subject 36,Screening,,Disposition,Form 2,,
Study 6,AUS,Site 14,Subject 36,Screening,Subject continuing,Screening,Form 1,4 NOV 2025,10
Study 6,AUS,Site 14,Subject 36,Screening,Subject continuing,Screening,Form 1,4 NOV 2025,10
Study 6,AUS,Site 14,Subject 36,Screening,Subject continuing,Screening,Form 1,4 NOV 2025,10
Study 6,AUS,Site 14,Subject 36,Screening,Subject continuing,Screening,Form 1,4 NOV 2025,10
Study 6,AUS,Site 15,Subject 39,On Trial,Subject continuing,Cycle 2 Week 8,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 39,On Trial,Subject continuing,Cycle 2 Week 8,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 39,On Trial,Subject continuing,Cycle 2 Week 8,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 39,On Trial,Subject continuing,Cycle 2 Week 8,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 39,On Trial,Subject continuing,Cycle 3 Week 1,Form 1,04 NOV 2025,10
Study 6,AUS,Site 15,Subject 39,On Trial,Subject continuing,Cycle 3 Week 1,Form 1,04 NOV 2025,10
Study 6,AUS,Site 15,Subject 39,On Trial,Subject continuing,Cycle 3 Week 1,Form 1,04 NOV 2025,10
Study 6,AUS,Site 15,Subject 39,On Trial,,Cycle 3 Week 5,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 39,On Trial,Subject continuing,Screening,Form 1,13 JUN 2025,154
Study 6,AUS,Site 15,Subject 39,On Trial,Subject continuing,Screening,Form 1,13 JUN 2025,154
Study 6,AUS,Site 15,Subject 40,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,5 AUG 2025,101
Study 6,AUS,Site 15,Subject 40,On Trial,,Cycle 2 Week 6,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 40,On Trial,Subject continuing,Screening,Form 1,27 JUN 2025,140
Study 6,AUS,Site 15,Subject 40,On Trial,Subject continuing,Screening,Form 1,27 JUN 2025,140
Study 6,AUS,Site 15,Subject 41,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,16 SEP 2025,59
Study 6,AUS,Site 15,Subject 41,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,16 SEP 2025,59
Study 6,AUS,Site 15,Subject 41,On Trial,,Cycle 1 Week 8,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 41,On Trial,Subject continuing,Screening,Form 1,15 AUG 2025,91
Study 6,AUS,Site 15,Subject 41,On Trial,Subject continuing,Screening,Form 1,15 AUG 2025,91
Study 6,AUS,Site 15,Subject 42,Screening,,Screening,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 42,Screening,,Screening,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 42,Screening,,Screening,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 42,Screening,,Screening,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 42,Screening,,Screening,Form 1,Missing visit date,
Study 6,AUS,Site 15,Subject 42,Screening,,Screening,Form 1,Missing visit date,
Study 6,CHN,Site 165,Subject 1512,Screen Failure,Subject discontinued from study at this visit,Screening,Form 1,21 APR 2025,207
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 3 Week 1,Form 1,16 SEP 2025,59
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 3 Week 8,Form 1,Missing visit date,
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 3 Week 8,Form 1,Missing visit date,
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Cycle 4 Week 1,Form 1,14 NOV 2025,0
Study 6,CHN,Site 165,Subject 1513,On Trial,,Cycle 4 Week 5,Form 1,Missing visit date,
Study 6,CHN,Site 165,Subject 1513,On Trial,Subject continuing,Screening,Form 1,6 MAY 2025,192
Study 6,CHN,Site 165,Subject 2586,Discontinued,,Non-drug therapies,Form 2,,
Study 6,CHN,Site 165,Subject 2586,Discontinued,Subject continuing,Screening,Form 1,24 JUL 2025,113
Study 6,CHN,Site 165,Subject 2587,Screening,,Disposition,Form 2,,
Study 6,CHN,Site 165,Subject 2587,Screening,Subject continuing,Screening,Form 1,20 OCT 2025,25
Study 6,CHN,Site 165,Subject 2587,Screening,Subject continuing,Screening,Form 1,20 OCT 2025,25
Study 6,CHN,Site 165,Subject 2587,Screening,Subject continuing,Screening,Form 1,20 OCT 2025,25
Study 6,CHN,Site 165,Subject 2587,Screening,Subject continuing,Screening,Form 1,20 OCT 2025,25
Study 6,CHN,Site 168,Subject 1520,Screen Failure,Subject discontinued from study at this visit,Screening,Form 1,29 JUL 2025,108
Study 6,ISR,Site 62,Subject 383,Screen Failure,,SAE/ADR,Form 2,,
Study 6,ISR,Site 62,Subject 383,Screen Failure,,SAE/ADR,Form 2,,
Study 6,ISR,Site 62,Subject 383,Screen Failure,,SAE/ADR,Form 2,,
Study 6,ISR,Site 62,Subject 383,Screen Failure,,SAE/ADR,Form 2,,
Study 6,ISR,Site 62,Subject 383,Screen Failure,,SAE/ADR,Form 2,,
Study 6,ISR,Site 62,Subject 383,Screen Failure,,SAE/ADR,Form 2,,
Study 6,ISR,Site 62,Subject 383,Screen Failure,,SAE/ADR,Form 2,,
Study 6,ISR,Site 62,Subject 383,Screen Failure,,SAE/ADR,Form 2,,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,16 SEP 2025,59
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,16 SEP 2025,59
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 1 Week 8,Form 1,6 NOV 2025,8
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 1 Week 8,Form 1,6 NOV 2025,8
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,,Cycle 2 Week 3,Form 1,Missing visit date,
Study 6,JPN,Site 191,Subject 1668,On Trial,,Disposition,Form 2,,
Study 6,JPN,Site 191,Subject 1668,On Trial,Subject continuing,Screening,Form 1,15 AUG 2025,91
Study 6,JPN,Site 191,Subject 1669,Screen Failure,Subject discontinued from study at this visit,Screening,Form 1,29 AUG 2025,77
Study 6,JPN,Site 352,Subject 2843,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,21 OCT 2025,24
Study 6,JPN,Site 352,Subject 2843,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,21 OCT 2025,24
Study 6,JPN,Site 352,Subject 2843,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,21 OCT 2025,24
Study 6,JPN,Site 352,Subject 2843,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,21 OCT 2025,24
Study 6,JPN,Site 352,Subject 2843,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,21 OCT 2025,24
Study 6,JPN,Site 352,Subject 2843,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,21 OCT 2025,24
Study 6,JPN,Site 352,Subject 2843,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,21 OCT 2025,24
Study 6,JPN,Site 352,Subject 2843,On Trial,,Cycle 1 Week 5,Form 1,Missing visit date,
Study 6,JPN,Site 352,Subject 2843,On Trial,,Disposition,Form 2,,
Study 6,JPN,Site 352,Subject 2843,On Trial,Subject continuing,Screening,Form 1,8 SEP 2025,67
Study 6,JPN,Site 352,Subject 2843,On Trial,Subject continuing,Screening,Form 1,8 SEP 2025,67
Study 6,JPN,Site 193,Subject 1698,On Trial,,Cycle 1 Week 5,Form 1,Missing visit date,
Study 6,JPN,Site 193,Subject 2780,Screening,,Cycle 1 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 193,Subject 2780,Screening,,Disposition,Form 2,,
Study 6,JPN,Site 193,Subject 2780,Screening,Subject continuing,Screening,Form 1,15 OCT 2025,30
Study 6,JPN,Site 193,Subject 2780,Screening,Subject continuing,Screening,Form 1,15 OCT 2025,30
Study 6,JPN,Site 193,Subject 2780,Screening,Subject continuing,Screening,Form 1,15 OCT 2025,30
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,,Cycle 2 Week 3,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1699,On Trial,Subject continuing,Screening,Form 1,27 AUG 2025,79
Study 6,JPN,Site 194,Subject 1700,Screening,,Cycle 1 Week 1,Form 1,Missing visit date,
Study 6,JPN,Site 194,Subject 1700,Screening,,Disposition,Form 2,,
Study 6,JPN,Site 345,Subject 2803,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,12 NOV 2025,2
Study 6,JPN,Site 345,Subject 2803,On Trial,,Cycle 1 Week 5,Form 1,Missing visit date,
Study 6,JPN,Site 345,Subject 2803,On Trial,,Disposition,Form 2,,
Study 6,JPN,Site 345,Subject 2803,On Trial,Subject continuing,Screening,Form 1,16 OCT 2025,29
Study 6,JPN,Site 345,Subject 2803,On Trial,Subject continuing,Screening,Form 1,16 OCT 2025,29
Study 6,JPN,Site 345,Subject 2803,On Trial,Subject continuing,Screening,Form 1,16 OCT 2025,29
Study 6,SGP,Site 349,Subject 2830,Discontinued,Subject continuing,Cycle 1 Week 1,Form 1,08 JUL 2025,129
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2830,Discontinued,,SAE/ADR,Form 2,,
Study 6,SGP,Site 349,Subject 2835,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,28 OCT 2025,17
Study 6,SGP,Site 349,Subject 2835,On Trial,,Cycle 1 Week 3,Form 1,Missing visit date,
Study 6,SGP,Site 349,Subject 2835,On Trial,Subject continuing,Screening,Form 1,16 SEP 2025,59
Study 6,SGP,Site 349,Subject 2835,On Trial,Subject continuing,Screening,Form 1,16 SEP 2025,59
Study 6,TWN,Site 351,Subject 2837,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,19 AUG 2025,87
Study 6,TWN,Site 351,Subject 2837,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,19 AUG 2025,87
Study 6,TWN,Site 351,Subject 2837,On Trial,Subject continuing,Cycle 1 Week 8,Form 1,9 OCT 2025,36
Study 6,TWN,Site 351,Subject 2837,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,21 OCT 2025,24
Study 6,TWN,Site 351,Subject 2837,On Trial,,Cycle 2 Week 3,Form 1,Missing visit date,
Study 6,TWN,Site 351,Subject 2837,On Trial,,Disposition,Form 2,,
Study 6,TWN,Site 351,Subject 2837,On Trial,Subject continuing,Screening,Form 1,16 JUL 2025,121
Study 6,TWN,Site 351,Subject 2837,On Trial,Subject continuing,Screening,Form 1,16 JUL 2025,121
Study 6,TWN,Site 351,Subject 2838,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,19 AUG 2025,87
Study 6,TWN,Site 351,Subject 2838,On Trial,Subject continuing,Cycle 1 Week 1,Form 1,19 AUG 2025,87
Study 6,TWN,Site 351,Subject 2838,On Trial,Subject continuing,Cycle 1 Week 5,Form 1,17 SEP 2025,58
Study 6,TWN,Site 351,Subject 2838,On Trial,Subject continuing,Cycle 1 Week 8,Form 1,8 OCT 2025,37
Study 6,TWN,Site 351,Subject 2838,On Trial,,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,TWN,Site 351,Subject 2838,On Trial,,Disposition,Form 2,,
Study 6,TWN,Site 351,Subject 2838,On Trial,Subject continuing,Screening,Form 1,17 JUL 2025,120
Study 6,TWN,Site 351,Subject 2839,Screen Failure,Subject discontinued from study at this visit,Screening,Form 1,16 SEP 2025,59
Study 6,USA,Site 20,Subject 82,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,12 NOV 2025,2
Study 6,USA,Site 20,Subject 82,On Trial,Subject continuing,Cycle 2 Week 1,Form 1,12 NOV 2025,2
Study 6,USA,Site 20,Subject 82,On Trial,,Cycle 2 Week 3,Form 1,Missing visit date,
Study 6,USA,Site 20,Subject 1601,On Trial,,Cycle 2 Week 1,Form 1,Missing visit date,
Study 6,USA,Site 20,Subject 1603,Screen Failure,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 1603,Screen Failure,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 1603,Screen Failure,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 1603,Screen Failure,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 1603,Screen Failure,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 1603,Screen Failure,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 1603,Screen Failure,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 1603,Screen Failure,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 2841,Discontinued,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 2841,Discontinued,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 2841,Discontinued,,SAE/ADR,Form 2,,
Study 6,USA,Site 20,Subject 2841,Discontinued,,SAE/ADR,Form 2,,
,,,,,,,,,
